593 related articles for article (PubMed ID: 2522978)
21. Evidence for a role in thrombus stabilization for thromboxane A2 in human platelet deposition on collagen.
Wagner WR; Hubbell JA
J Lab Clin Med; 1992 Jun; 119(6):690-7. PubMed ID: 1534345
[TBL] [Abstract][Full Text] [Related]
22. Platelet deposition induced by severely damaged vessel wall is inhibited by a boroarginine synthetic peptide with antithrombin activity.
Badimon JJ; Weng D; Chesebro JH; Fuster V; Badimon L
Thromb Haemost; 1994 Apr; 71(4):511-6. PubMed ID: 8052972
[TBL] [Abstract][Full Text] [Related]
23. Iloprost reduces procoagulant activity in the extracorporeal circuit.
Korn RL; Fisher CA; Stenach N; Jeevanandam V; Addonizio VP
J Surg Res; 1993 Oct; 55(4):433-40. PubMed ID: 7692141
[TBL] [Abstract][Full Text] [Related]
24. [Inactivated factor VII exercises a powerful antithrombotic activity in an experimental model of recurrent arterial thrombosis].
Ragni M; Golino P; Cirillo P; Pascucci I; Scognamiglio A; Ravera A; Esposito N; Battaglia C; Guarino A; Chiariello M
Cardiologia; 1996 Jan; 41(1):51-8. PubMed ID: 8697470
[TBL] [Abstract][Full Text] [Related]
25. Antithrombotic effects of combining activated protein C and urokinase in nonhuman primates.
Gruber A; Harker LA; Hanson SR; Kelly AB; Griffin JH
Circulation; 1991 Dec; 84(6):2454-62. PubMed ID: 1835678
[TBL] [Abstract][Full Text] [Related]
26. Selective PF4 release in vitro induced by heparin and related glycosaminoglycans (GAGs)--correlation with beta-TG release and platelet aggregation.
Cofrancesco E; Colombi M; Cristoforetti G; Pogliani EM
Thromb Haemost; 1984 Feb; 51(1):105-7. PubMed ID: 6202020
[TBL] [Abstract][Full Text] [Related]
27. Antithrombotic effects of thrombin-induced activation of endogenous protein C in primates.
Hanson SR; Griffin JH; Harker LA; Kelly AB; Esmon CT; Gruber A
J Clin Invest; 1993 Oct; 92(4):2003-12. PubMed ID: 8408654
[TBL] [Abstract][Full Text] [Related]
28. Role of factor VIII-von Willebrand factor and fibronectin in the interaction of platelets in flowing blood with monomeric and fibrillar human collagen types I and III.
Houdijk WP; Sakariassen KS; Nievelstein PF; Sixma JJ
J Clin Invest; 1985 Feb; 75(2):531-40. PubMed ID: 3919060
[TBL] [Abstract][Full Text] [Related]
29. Platelet compatibility of an artificial surface modified with functionally active heparin.
Mollnes TE; Videm V; Christiansen D; Bergseth G; Riesenfeld J; Hovig T
Thromb Haemost; 1999 Sep; 82(3):1132-6. PubMed ID: 10494777
[TBL] [Abstract][Full Text] [Related]
30. Studies of suloctidil in experimental thrombosis in baboons.
Hanson SR; Harker LA
Thromb Haemost; 1985 Jun; 53(3):423-7. PubMed ID: 2996168
[TBL] [Abstract][Full Text] [Related]
31. Transient interruption of arterial thrombosis by inhibition of factor Xa results in long-term antithrombotic effects in baboons.
Kotzé HF; Lamprecht S; Badenhorst PN; Roodt JP; van Wyk V
Thromb Haemost; 1997 Jun; 77(6):1137-42. PubMed ID: 9241746
[TBL] [Abstract][Full Text] [Related]
32. Selective inhibition by a synthetic hirudin peptide of fibrin-dependent thrombosis in baboons.
Cadroy Y; Maraganore JM; Hanson SR; Harker LA
Proc Natl Acad Sci U S A; 1991 Feb; 88(4):1177-81. PubMed ID: 1996320
[TBL] [Abstract][Full Text] [Related]
33. Aspirin-independent antithrombotic effects of acutely attached cultured endothelial cells on endarterectomized arteries.
Krupski WC; Bass A; Anderson JS; Kelly AB; Harker LA
Surgery; 1990 Aug; 108(2):283-90; discussion 290-1. PubMed ID: 2382225
[TBL] [Abstract][Full Text] [Related]
34. Dermatan sulfate inhibition of fibrin-rich thrombus formation in nonhuman primates.
Cadroy Y; Hanson SR; Harker LA
Arterioscler Thromb; 1993 Aug; 13(8):1213-7. PubMed ID: 8343496
[TBL] [Abstract][Full Text] [Related]
35. Effect of heparin bonding on catheter-induced fibrin formation and platelet activation.
Nichols AB; Owen J; Grossman BA; Marcella JJ; Fleisher LN; Lee MM
Circulation; 1984 Nov; 70(5):843-50. PubMed ID: 6237807
[TBL] [Abstract][Full Text] [Related]
36. Role of collagen-adherent platelets in mediating fibrin formation in flowing whole blood.
Kirchhofer D; Tschopp TB; Steiner B; Baumgartner HR
Blood; 1995 Nov; 86(10):3815-22. PubMed ID: 7579349
[TBL] [Abstract][Full Text] [Related]
37. Antithrombotic effects of synthetic peptides targeting various functional domains of thrombin.
Kelly AB; Maraganore JM; Bourdon P; Hanson SR; Harker LA
Proc Natl Acad Sci U S A; 1992 Jul; 89(13):6040-4. PubMed ID: 1385867
[TBL] [Abstract][Full Text] [Related]
38. Platelet function in sickle cell disease during steady state.
Triadou P; Fonty E; Ambrosio AS; Cottat MC; Girot R; Cornu P
Nouv Rev Fr Hematol (1978); 1990; 32(2):137-42. PubMed ID: 2143013
[TBL] [Abstract][Full Text] [Related]
39. Experimental arterial thromboembolism in baboons. Mechanism, quantitation, and pharmacologic prevention.
Harker LA; Hanson SR
J Clin Invest; 1979 Aug; 64(2):559-60. PubMed ID: 110835
[TBL] [Abstract][Full Text] [Related]
40. Prevention of heparin-resistant thrombotic occlusion of hollow-fiber hemodialyzers by synthetic antithrombin.
Kelly AB; Hanson SR; Henderson LW; Harker LA
J Lab Clin Med; 1989 Oct; 114(4):411-8. PubMed ID: 2794754
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]